Remove Academic Remove Cardio Oncology Remove Preserved Ejection Fraction
article thumbnail

Highlights of ACC 2024

Cardiology Update

STEP-HFpEF DM 5 ( NCT04916470 ) explored the effects of semaglutide in obesity-related HF with preserved ejection fraction (HFpEF) and type 2 diabetes. The primary superiority endpoint was clinically relevant bleeding (Bleeding Academic Research Consortium [known as BARC] types 2, 3, or 5).